MRI surveillance for musculoskeletal sarcoma recurrence: is axial-only imaging good enough?

Key Points

• Axial-only MRI surveillance may miss recurrence of musculoskeletal sarcoma, impacting patient outcomes.
• Study found that 30% of recurrences detected by full-body imaging were not visible on axial-only scans.
• Assessment of imaging effectiveness was performed using retrospective analysis of imaging records from 150 patients.
• Highlights the importance of comprehensive imaging in improving early detection of potential recurrences.